I agree 100%. Placing the strip in the mouth is easier for the patient to administer the meds over an inhaler. Cynaf has been significantly derisked after the recent results. Acorda bought the wrong company. Cynaf would be a strong acquisition for a bigger company given the results. I heard cynaf gave a presentation a few weeks ago to a packed house. A few days ago the stock took off on some big buys. Someone wanted in badly driving the price up. Stock is significantly undervalued at these levels.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.